ARCHIVES

Targeting Men At High Risk Finds More Head & Neck Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

DCPC Planning 10 More Prevention Fellowship Awards

August 14, 1987

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

October 3, 1997